0001179110-17-013545.txt : 20171030 0001179110-17-013545.hdr.sgml : 20171030 20171030193013 ACCESSION NUMBER: 0001179110-17-013545 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171027 FILED AS OF DATE: 20171030 DATE AS OF CHANGE: 20171030 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Misfeldt Dayton CENTRAL INDEX KEY: 0001461466 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51531 FILM NUMBER: 171163723 MAIL ADDRESS: STREET 1: C/O BAY CITY CAPITAL LLC STREET 2: 750 BATTERY STREET, SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUNESIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001061027 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943295878 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 395 OYSTER POINT BOULEVARD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-3500 MAIL ADDRESS: STREET 1: 395 OYSTER POINT BOULEVARD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19980709 4 1 edgar.xml FORM 4 - X0306 4 2017-10-27 0 0001061027 SUNESIS PHARMACEUTICALS INC SNSS 0001461466 Misfeldt Dayton C/O BAY CITY CAPITAL LLC 750 BATTERY STREET, SUITE 400 SAN FRANCISCO CA 94111 1 0 0 0 Common Stock 2017-10-27 4 P 0 392520 2.0 A 1598260 I See footnotes. Common Stock 2017-10-27 4 P 0 7480 2.0 A 30456 I See footnotes. Common Stock 252 I See footnotes. Common Stock Warrants (right to buy) 3.00 2017-10-27 4 P 0 196260 A 2017-10-27 2018-10-27 Common Stock 196260 196260 I See footnotes. Common Stock Warrants (right to buy) 3.0 2017-10-27 4 P 0 3740 A 2017-10-27 2018-10-27 Common Stock 3740 3740 I See footnotes. The reporting person is a Managing Director of Bay City Capital LLC, a Delaware limited liability company ("BCC"). BCC is the manager of Bay City Capital Management V LLC, a Delaware limited liability company ("Management V"). Management V is the general partner of Bay City Capital Fund V, L.P., a Delaware limited partnership ("Fund V") and Bay City Capital Fund V Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment V") and has sole voting and dispositive power with respect to the securities held by Fund V and Co-Investment V. BCC, the manager of Management V, is also an advisor to Fund V and Co-Investment V and has sole voting and dispositive power with respect to the securities held. Mr. Misfeldt, BCC and Management V disclaim beneficial ownership with respect to the securities reported in this Form 4, except to the extent of their pecuniary interest therein. The securities are held by Fund V. The securities are held by Co-Investment V. The securities are held by BCC. The reported securities are included within the 392,520 shares of common stock and accompanying warrants purchased by the reporting person. The per share price of $2.00 includes one share of common stock and the accompanying warrant to purchase 0.5 share of common stock. The reported securities are included within the 7,480 shares of common stock purchased by the reporting person. The per share price of $2.00 includes one share of common stock and the accompanying warrant to purchase 0.5 share of common stock. /s/ Dayton Misfeldt 2017-10-30